Mitogen-activated protein kinase phosphatase 1 regulates bone mass, osteoblast gene expression, and responsiveness to parathyroid hormone

Journal of Endocrinology

Volumn 211, Issue 2, 2011, Pages 145-156

  Mahalingam, Chandrika D ^a   Datta, Tanuka ^a   Patil, Rashmi V ^a   Kreider, Jaclynn ^b   Bonfil, R Daniel ^a   Kirkwood, Keith L ^c   Goldstein, Steven A ^b   Abou Samra, Abdul B ^a   Datta, Nabanita S ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; ALKALINE PHOSPHATASE; CYCLIN D1; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1; OSTEOCALCIN; PARATHYROID HORMONE; PARATHYROID HORMONE RECEPTOR 1; TARTRATE RESISTANT ACID PHOSPHATASE 5B; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MASS; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; FEMUR; GENE; GENE EXPRESSION; HORMONE RESPONSE; HUMAN; KNOCKOUT MOUSE; MICRO-COMPUTED TOMOGRAPHY; MORPHOMETRICS; MOUSE; NONHUMAN; OCN GENE; OSTEOBLAST; OSTEOPENIA; PRIORITY JOURNAL; RUNX2 GENE; TIBIA; TRABECULAR BONE; WILD TYPE;

ACID PHOSPHATASE; ANIMALS; ANIMALS, NEWBORN; BLOTTING, WESTERN; BONE AND BONES; CELL DIFFERENTIATION; CELL LINE; CELLS, CULTURED; CORE BINDING FACTOR ALPHA 1 SUBUNIT; CYCLIN D1; DUAL SPECIFICITY PHOSPHATASE 1; FEMALE; GENE EXPRESSION; ISOENZYMES; MALE; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, KNOCKOUT; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; OSTEOBLASTS; OSTEOCALCIN; PARATHYROID HORMONE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; X-RAY MICROTOMOGRAPHY;

EID: 83455225042     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1530/JOE-11-0144     Document Type: Article

References (78)

1. Aghaloo TL, Pirih FQ, Shi A, Bezouglaia O & Tetradis S 2006 Parathyroid hormone induces mitogen-activated kinase phosphatase 1 in murine osteoblasts primarily through cAMP-protein kinase A signaling. Journal of Periodontology 77 21-30.
2. Alves de Oliveira EC, Szejnfeld VL, Pereira da Silva N, Coelho Andrade LE & Heldan de Moura Castro C 2010 Intermittent PTH1-34 causes DNA and chromosome breaks in osteoblastic and nonosteoblastic cells. Calcified Tissue International 87 424-436.
3. Andreassen TT, Fledelius C, Ejersted C & Oxlund H 2001 Increases in callus formation and mechanical strength of healing fractures in old rats treated with parathyroid hormone. Acta Orthopaedica Scandinavica 72 304-307.
4. Beamer WG, Donahue LR & Rosen CJ 2002 Genetics and bone. Using the mouse to understand man. Journal of Musculoskeletal & Neuronal Interactions 2 225-231.
5. Beamer WG, Shultz KL, Ackert-Bicknell CL, Horton LG, Delahunty KM, Coombs HF III, Donahue LR, Canalis E & Rosen CJ 2007 Genetic dissection of mouse distal chromosome 1 reveals three linked BMD QTLs with sex-dependent regulation of bone phenotypes. Journal of Bone and Mineral Research 22 1187-1196.
6. Callewaert F, Sinnesael M, Gielen E, Boonen S & Vanderschueren D 2010 Skeletal sexual dimorphism: relative contribution of sex steroids, GH-IGF1, and mechanical loading. Journal of Endocrinology 207 127-134.
7. Calvi LM, Sims NA, Hunzelman JL, Knight MC, Giovannetti A, Saxton JM, Kronenberg HM, Baron R & Schipani E 2001 Activated parathyroid hormone/parathyroid hormone-related protein receptor in osteoblastic cells differentially affects cortical and trabecular bone. Journal of Clinical Investigation 107 277-286.
8. Carlson J, CuiW, Zhang Q, Xu X, Mercan F, Bennett AM& Vignery A 2009 Role of MKP-1 in osteoclasts and bone homeostasis. American Journal of Pathology 175 1564-1573.
9. Chen C, Koh AJ, Datta NS, Zhang J, Keller ET, Xiao G, Franceschi RT, D'Silva NJ & McCauley LK 2004 Impact of the mitogen-activated protein kinase pathway on parathyroid hormone-related protein actions in osteoblasts. Journal of Biological Chemistry 279 29121-29129.
10. Cheng SL, Yang JW, Rifas L, Zhang SF & Avioli LV 1994 Differentiation of human bone marrow osteogenic stromal cells in vitro: induction of the osteoblast phenotype by dexamethasone. Endocrinology 134 277-286.
11. Chi H, Barry SP, Roth RJ, Wu JJ, Jones EA, Bennett AM & Flavell RA 2006 Dynamic regulation of pro- and anti-inflammatory cytokines by MAPK phosphatase 1 (MKP-1) in innate immune responses. PNAS 103 2274-2279.
12. Chung HY, Cesari M, Anton S, Marzetti E, Giovannini S, Seo AY, Carter C, Yu BP & Leeuwenburgh C 2009 Molecular inflammation: underpinnings of aging and age-related diseases. Ageing Research Reviews 8 18-30.
13. Cobb MH 1999 MAP kinase pathways. Progress in Biophysics and Molecular Biology 71 479-500.
14. Datta NS & Abou-Samra AB 2009 PTH and PTHrP signaling in osteoblasts. Cellular Signalling 21 1245-1254.
15. Datta NS, Chen C, Berry JE & McCauley LK 2005 PTHrP signaling targets cyclin D1 and induces osteoblastic cell growth arrest. Journal of Bone and Mineral Research 20 1051-1064.
16. Datta NS, Kolailat R, Pettway GJ, Berry JE &McCauley LK 2007a Induction of mitogen-activated protein kinase phosphatase-1 and down-regulation of p38 and ERK1/2 phosphorylation in PTHrP stimulated differentiated osteoblasts. The FASEB Journal 21 768.4.
17. Datta NS, Pettway GJ, Chen C, Koh AJ & McCauley LK 2007b Cyclin D1 as a target for the proliferative effects of PTH and PTHrP in early osteoblastic cells. Journal of Bone and Mineral Research 22 951-964.
18. Datta NS, Kolailat R, Fite A, Pettway G & Abou-Samra AB 2010a Distinct roles for mitogen-activated protein kinase phosphatase-1 (MKP-1) and ERK-MAPK in PTH1R signaling during osteoblast proliferation and differentiation. Cellular Signalling 22 457-466.
19. Datta NS, Mahalingam CD, Kreider J, Kirkwood K, Goldstein SA & Abou-Samra AB 2010b MKP-1 knockout mice reveal sexual dimorphism in bone mass and disperate PTHrP responsiveness of primary calvarial osteoblasts. American Society of Bone and Mineral Research Annual Conference, SU0116, Toronto, Canada.
20. Datta NS, Samra TA, Mahalingam CD, Datta T & Abou-Samra AB 2010c Role of PTH1R internalization in osteoblasts and bone mass using a phosphorylation-deficient knock-in mouse model. Journal of Endocrinology 207 355-365.
21. Delahunty KM, Shultz KL, Gronowicz GA, Koczon-Jaremko B, Adamo ML, Horton LG, Lorenzo J, Donahue LR, Ackert-Bicknell C, Kream BE et al. 2006 Congenic mice provide in vivo evidence for a genetic locus that modulates serum insulin-like growth factor-I and bone acquisition. Endocrinology 147 3915-3923.
22. DeMambro VE, Kawai M, Clemens TL, Fulzele K, Maynard JA, Marin de Evsikova C, Johnson KR, Canalis E, Beamer WG, Rosen CJ et al. 2010 A novel spontaneous mutation of Irs1 in mice results in hyperinsulinemia, reduced growth, low bone mass and impaired adipogenesis. Journal of Endocrinology 204 241-253.
23. Demiralp B, Chen HL, Koh AJ, Keller ET & McCauley LK 2002 Anabolic actions of parathyroid hormone during bone growth are dependent on c-fos. Endocrinology 143 4038-4047.
24. DempsterDW, Cosman F, Kurland ES, Zhou H, Nieves J, Woelfert L, Shane E, Plavetic K, Muller R, Bilezikian J et al. 2001 Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: a paired biopsy study. Journal of Bone and Mineral Research 16 1846-1853.
25. Dobnig H & Turner RT 1997 The effects of programmed administration of human parathyroid hormone fragment (1-34) on bone histomorphometry and serum chemistry in rats. Endocrinology 138 4607-4612.
26. Dorfman K, Carrasco D, Gruda M, Ryan C, Lira SA & Bravo R 1996 Disruption of the erp/mkp-1 gene does not affect mouse development: normal MAP kinase activity in ERP/MKP-1-deficient fibroblasts. Oncogene 13 925-931.
27. English J, Pearson G, Wilsbacher J, Swantek J, Karandikar M, Xu S & Cobb MH 1999 New insights into the control of MAP kinase pathways. Experimental Cell Research 253 255-270.
28. Franceschi RT & Xiao G 2003 Regulation of the osteoblast-specific transcription factor, Runx2: responsiveness to multiple signal transduction pathways. Journal of Cellular Biochemistry 88 446-454.
29. Ge C, Xiao G, Jiang D & Franceschi RT 2007 Critical role of the extracellular signal-regulated kinase-MAPK pathway in osteoblast differentiation and skeletal development. Journal of Cell Biology 176 709-718.
30. Gopalakrishnan R, Ouyang H, Somerman MJ, McCauley LK & Franceschi RT 2001 Matrix gamma-carboxyglutamic acid protein is a key regulator of PTH-mediated inhibition of mineralization in MC3T3-E1 osteoblast-like cells. Endocrinology 142 4379-4388.
31. Greenblatt MB, Shim JH, Zou W, Sitara D, Schweitzer M, Hu D, Lotinun S, Sano Y, Baron R, Park JM et al. 2010 The p38 MAPK pathway is essential for skeletogenesis and bone homeostasis in mice. Journal of Clinical Investigation 120 2457-2473.
32. Higuchi C, Myoui A, Hashimoto N, Kuriyama K, Yoshioka K, Yoshikawa H & Itoh K 2002 Continuous inhibition of MAPK signaling promotes the early osteoblastic differentiation and mineralization of the extracellular matrix. Journal of Bone and Mineral Research 17 1785-1794.
33. Hock JM, Fitzpatrick LA & Bilezikian JP 2002 Actions of parathyroid hormone. In Principles of Bone Biology, 2nd, pp 463-482. Eds JP Bilezikian, LG Raisz & GA Rodan. San Diego: Academic Press.
34. Hoemann CD, El-Gabalawy H & McKee MD 2009 In vitro osteogenesis assays: influence of the primary cell source on alkaline phosphatase activity and mineralization. Pathologie-Biologie 57 318-323.
35. Homme M, Schmitt CP, Mehls O & Schaefer F 2004 Mechanisms of mitogen-activated protein kinase inhibition by parathyroid hormone in osteoblast-like cells. Journal of the American Society of Nephrology 15 2844-2850.
36. Isogai Y, Akatsu T, Ishizuya T, Yamaguchi A, Hori M, Takahashi N & Suda T 1996 Parathyroid hormone regulates osteoblast differentiation positively or negatively depending on the differentiation stages. Journal of Bone and Mineral Research 11 1384-1393.
37. Jahng JS & Kim HW 2000 Effect of intermittent administration of parathyroid hormone on fracture healing in ovariectomized rats. Orthopedics 23 1089-1094.
38. Jiang D, Franceschi RT, Boules H & Xiao G 2004 Parathyroid hormone induction of the osteocalcin gene. Requirement for an osteoblast-specific element 1 sequence in the promoter and involvement of multiple-signaling pathways. Journal of Biological Chemistry 279 5329-5337.
39. Jilka RL 2007 Molecular and cellular mechanisms of the anabolic effect of intermittent PTH. Bone 40 1434-1446.
40. Karaplis AC, Luz A, Glowacki J, Bronson RT, Tybulewicz VL, Kronenberg HM &Mulligan RC 1994 Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene. Genes and Development 8 277-289.
41. Keyse SM 2000 Protein phosphatases and the regulation of mitogen-activated protein kinase signalling. Current Opinion in Cell Biology 12 186-192.
42. Kitahara K, Ishijima M, Rittling SR, Tsuji K, Kurosawa H, Nifuji A, Denhardt DT & Noda M 2003 Osteopontin deficiency induces parathyroid hormone enhancement of cortical bone formation. Endocrinology 144 2132-2140.
43. Koh AJ, Beecher CA, Rosol TJ &McCauley LK 1999 30,50-Cyclic adenosine monophosphate activation in osteoblastic cells: effects on parathyroid hormone-1 receptors and osteoblastic differentiation in vitro. Endocrinology 140 3154-3162.
44. Lai LP & Mitchell J 2009 Parathyroid hormone inhibits phosphorylation of mitogen-activated protein kinase (MAPK) ERK1/2 through inhibition of c-Raf and activation of MKP-1 in osteoblastic cells. Cell Biochemistry and Function 27 269-275.
45. Lanske B, Amling M, Neff L, Guiducci J, Baron R & Kronenberg HM 1999 Ablation of the PTHrP gene or the PTH/PTHrP receptor gene leads to distinct abnormalities in bone development. Journal of Clinical Investigation 104 399-407.
46. Luo G, D'Souza R, Hogue D & Karsenty G 1995 The matrix Gla protein gene is a marker of the chondrogenesis cell lineage during mouse development. Journal of Bone and Mineral Research 10 325-334.
47. Luo G, Ducy P, McKee MD, Pinero GJ, Loyer E, Behringer RR & Karsenty G 1997 Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 386 78-81.
48. Ma L, Choudhary S, Voznesensky O, Raisz L & Pilbeam C 2009 Effects of MKP-1 deletion on osteoblast growth and differentiation. American Society of Bone and Mineral Research (ASBMR) Annual Conference, pp MO 0186, Denver, CO, USA.
49. Machado do Reis L, Kessler CB, Adams DJ, Lorenzo J, Jorgetti V & Delany AM 2008 Accentuated osteoclastic response to parathyroid hormone undermines bone mass acquisition in osteonectin-null mice. Bone 43 264-273.
50. Marsh ME, Munne AM, Vogel JJ, Cui Y & Franceschi RT 1995 Mineralization of bone-like extracellular matrix in the absence of functional osteoblasts. Journal of Bone and Mineral Research 10 1635-1643.
51. Marx SJ 2000 Hyperparathyroid and hypoparathyroid disorders. New England Journal of Medicine 343 1863-1875.
52. Miao D, He B, Karaplis AC & Goltzman D 2002 Parathyroid hormone is essential for normal fetal bone formation. Journal of Clinical Investigation 109 1173-1182.
53. Nakayama K, Tamura Y, Suzawa M, Harada S, Fukumoto S, Kato M, Miyazono K, Rodan GA, Takeuchi Y & Fujita T 2003 Receptor tyrosine kinases inhibit bone morphogenetic protein-Smad responsive promoter activity and differentiation of murine MC3T3-E1 osteoblast-like cells. Journal of Bone and Mineral Research 18 827-835.
54. Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY, Hodsman AB, Eriksen EF, Ish-Shalom S, Genant HK et al. 2001 Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. New England Journal of Medicine 344 1434-1441.
55. Nishida S, Yamaguchi A, Tanizawa T, Endo N, Mashiba T, Uchiyama Y, Suda T, Yoshiki S & Takahashi HE 1994 Increased bone formation by intermittent parathyroid hormone administration is due to the stimulation of proliferation and differentiation of osteoprogenitor cells in bone marrow. Bone 15 717-723.
56. Pearson G, Robinson F, Beers Gibson T, Xu BE, Karandikar M, Berman K & Cobb MH 2001 Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocrine Reviews 22 153-183.
57. Pietrogrande L 2010 Update on the efficacy, safety, and adherence to treatment of full length parathyroid hormone, PTH (1-84), in the treatment of postmenopausal osteoporosis. International Journal of Women's Health 1 193-203.
58. Price PA 1989 Gla-containing proteins of bone. Connective Tissue Research 21 51-57; discussion 57-60.
59. Qin L, Li X, Ko JK & Partridge NC 2005 Parathyroid hormone uses multiple mechanisms to arrest the cell cycle progression of osteoblastic cells from G1 to S phase. Journal of Biological Chemistry 280 3104-3111.
60. Rihani-Bisharat S, Maor G & Lewinson D 1998 In vivo anabolic effects of parathyroid hormone (PTH) 28-48 and N-terminal fragments of PTH and PTH-related protein on neonatal mouse bones. Endocrinology 139 974-981.
61. Salojin KV, Owusu IB, Millerchip KA, Potter M, Platt KA & Oravecz T 2006 Essential role of MAPK phosphatase-1 in the negative control of innate immune responses. Journal of Immunology 176 1899-1907.
62. Sartori R, Li F & Kirkwood KL 2009 MAP kinase phosphatase-1 protects against inflammatory bone loss. Journal of Dental Research 88 1125-1130.
63. Sato M, Yasui N, Nakase T, Kawahata H, Sugimoto M, Hirota S, Kitamura Y, Nomura S & Ochi T 1998 Expression of bone matrix proteins mRNA during distraction osteogenesis. Journal of Bone and Mineral Research 13 1221-1231.
64. Schiller PC, D'Ippolito G, Roos BA & Howard GA 1999 Anabolic or catabolic responses of MC3T3-E1 osteoblastic cells to parathyroid hormone depend on time and duration of treatment. Journal of Bone and Mineral Research 14 1504-1512.
65. Schindeler A & Little DG 2006 Ras-MAPK signaling in osteogenic differentiation: friend or foe? Journal of Bone and Mineral Research 21 1331-1338
66. Suttamanatwong S, Franceschi RT, Carlson AE & Gopalakrishnan R 2007 Regulation of matrix Gla protein by parathyroid hormone in MC3T3-E1 osteoblast-like cells involves protein kinase A and extracellular signalregulated kinase pathways. Journal of Cellular Biochemistry 102 496-505.
67. Swarthout JT, Doggett TA, Lemker JL & Partridge NC 2001 Stimulation of extracellular signal-regulated kinases and proliferation in rat osteoblastic cells by parathyroid hormone is protein kinase C-dependent. Journal of Biological Chemistry 276 7586-7592.
68. Theodosiou A & Ashworth A 2002 MAP kinase phosphatases. Genome Biology 3 1-10.
69. Turner CH, Sun Q, Schriefer J, Pitner N, Price R, Bouxsein ML, Rosen CJ, Donahue LR, Shultz KL & Beamer WG 2003 Congenic mice reveal sexspecific genetic regulation of femoral structure and strength. Calcified Tissue International 73 297-303.
70. Wang D, Christensen K, Chawla K, Xiao G, Krebsbach PH & Franceschi RT 1999 Isolation and characterization of MC3T3-E1 preosteoblast subclones with distinct in vitro and in vivo differentiation/mineralization potential. Journal of Bone and Mineral Research 14 893-903.
71. Weir EC, Philbrick WM, Amling M, Neff LA, Baron R & Broadus AE 1996 Targeted overexpression of parathyroid hormone-related peptide in chondrocytes causes chondrodysplasia and delayed endochondral bone formation. PNAS 93 10240-10245.
72. Wu JJ & Bennett AM 2005 Essential role for mitogen-activated protein (MAP) kinase phosphatase-1 in stress-responsive MAP kinase and cell survival signaling. Journal of Biological Chemistry 280 16461-16466.
73. Yang D, Singh R, Divieti P, Guo J, Bouxsein ML & Bringhurst FR 2007 Contributions of parathyroid hormone (PTH)/PTH-related peptide receptor signaling pathways to the anabolic effect of PTH on bone. Bone 40 1453-1461.
74. Yoshitake H, Rittling SR, Denhardt DT & Noda M 1999 Osteopontindeficient mice are resistant to ovariectomy-induced bone resorption. PNAS 96 8156-8160.
75. Zhang B, Hosaka M, Sawada Y, Torii S, Mizutani S, Ogata M, Izumi T & Takeuchi T 2003 Parathyroid hormone-related protein induces insulin expression through activation of MAP kinase-specific phosphatase-1 that dephosphorylates c-Jun NH2-terminal kinase in pancreatic beta-cells. Diabetes 52 2720-2730.
76. Zhao Q, Shepherd EG, Manson ME, Nelin LD, Sorokin A & Liu Y 2005 The role of mitogen-activated protein kinase phosphatase-1 in the response of alveolar macrophages to lipopolysaccharide: attenuation of proinflammatory cytokine biosynthesis via feedback control of p38. Journal of Biological Chemistry 280 8101-8108.
77. Zhong M, Carney DH, Jo H, Boyan BD & Schwartz Z 2011 Inorganic phosphate induces mammalian growth plate chondrocyte apoptosis in a mitochondrial pathway involving nitric oxide and JNK MAP kinase. Calcified Tissue International 88 96-108.
78. Zhou H, Shen V, Dempster DW & Lindsay R 2001 Continuous parathyroid hormone and estrogen administration increases vertebral cancellous bone volume and cortical width in the estrogen-deficient rat. Journal of Bone and Mineral Research 16 1300-1307.